Mangoceuticals, Inc. (MGRX): Total Liabilities
$890.6K
As of 2025-12-31
$1.65M
As of 2026-06-30
+31.8%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $890.6K | -37.5% | 2026-04-01, Balance as of period end |
| 2024-12-31 | $1.43M | +416.4% | 2026-04-01, Balance as of period end |
| 2023-12-31 | $276.0K | -29.1% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $389.3K | n/a | 2024-04-01, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Mangoceuticals, Inc. (MGRX) | 2025-12-31 | $890.6K | -37.5% |
| BioRestorative Therapies, Inc. (BRTX) | 2024-12-31 | $3.75M | +43.8% |
| Charming Medical Ltd (MCTA) | 2026-03-31 | $4.69M | -11.7% |
| Pacific Health Care Organization Inc (PFHO) | 2024-12-31 | $745.6K | -21.4% |
| Marpai, Inc. (MRAI) | 2025-12-31 | $43.47M | +7.1% |
| Cryo Cell International Inc (CCEL) | 2025-11-30 | $80.33M | +3.1% |
| Viemed Healthcare, Inc. (VMD) | 2025-12-31 | $55.63M | +27.1% |
| Sotera Health Co (SHC) | 2025-12-31 | $2.66B | -0.4% |
| Progyny, Inc. (PGNY) | 2025-12-31 | $226.39M | +22.3% |
Compare MGRX, BRTX, MCTA, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗